Finance

Lists
MARKSANS:NSE
Marksans Pharma Ltd
၃၁၀.၈၀ ₹
+၀.၉၆%
(+၂.၉၅) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MARKSANS...
Open
၃၀၈.၁၀ ₹
High
၃၁၃.၅၀ ₹
Low
၃၀၆.၀၀ ₹
Mkt. cap
ဋေ ၁.၄၁ သ
Avg. vol.
၂.၂၅ သန်း
Volume
၇.၆၈ သိန်း
Dividend
၀.၂၉%
Quarterly dividend
၀.၂၂ ₹
Ex-dividend date
၂၀၂၆ ဩ ၂၀
P/E ratio
၂၇.၂၄
52-wk high
၃၅၀.၉၅ ₹
52-wk low
၁၅၅.၀၀ ₹
EPS
၁၁.၄၁ ₹
Shares outstanding
၄၀.၉၃ ကုဋေ
No. of employees
၂ ထောင်
Open
၃၀၈.၁၀ ₹
High
၃၁၃.၅၀ ₹
Low
၃၀၆.၀၀ ₹
Mkt. cap
ဋေ ၁.၄၁ သ
Avg. vol.
၂.၂၅ သန်း
Volume
၇.၆၈ သိန်း
Dividend
၀.၂၉%
Quarterly dividend
၀.၂၂ ₹
Ex-dividend date
၂၀၂၆ ဩ ၂၀
P/E ratio
၂၇.၂၄
52-wk high
၃၅၀.၉၅ ₹
52-wk low
၁၅၅.၀၀ ₹
EPS
၁၁.၄၁ ₹
Shares outstanding
၄၀.၉၃ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
01net
01net
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight as the Agentic Foundation for Its Up to $1 Billion Tokenized Solar and AI Computing Program with Meridian and Up to $130 Million IP-Backed Transaction with BeyondAI
Chosunbiz
Chosunbiz
·
ပြီးခဲ့သည့် ၃၄ မိနစ်
FSS chief labels Solidigm Nasdaq move duplicate listing, presses SK hynix - CHOSUNBIZ
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
What Viasat Doubters Got Wrong
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Michael Burry Warns of a Stock Market ‘Supervolcano’
About Marksans Pharma Ltd
CEOMark B. Saldanha
Employees၁.၆၈ ထောင်
Founded၁၉၉၂
Headquarters-
Sector-
Websitemarksanspharma.com
Last report
၂၀၂၆ ဩ ၁၃
Fiscal period
Q1 2027
၃.၄၇ ₹ / ၃.၃၀ ₹
+၅.၁၅%beat
Revenue / Est. (INR)
၈၄၀.၈၀ ဋေ / ၈၅၀.၂၅ ဋေ
-၁.၁၁%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၇၂၀.၄၁ ဋေ
၇၅၄.၄၃ ဋေ
၈၅၆.၁၁ ဋေ
၈၄၀.၈၀ ဋေ
Cost of goods sold
၃၀၈.၅၉ ဋေ
၃၁၆.၂၂ ဋေ
၄၅၁.၂၃ ဋေ
၃၄၃.၄၇ ဋေ
Cost of revenue
၃၀၈.၅၉ ဋေ
၃၁၆.၂၂ ဋေ
၄၅၁.၂၃ ဋေ
၃၄၃.၄၇ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၀၃.၈၀ ဋေ
၁၁၁.၉၉ ဋေ
၁၂၀.၈၃ ဋေ
၁၁၄.၂၉ ဋေ
Operating expense
၂၉၄.၂၄ ဋေ
၃၀၁.၇၉ ဋေ
၂၃၃.၃၁ ဋေ
၃၀၉.၁၆ ဋေ
Total operating expenses
၆၀၂.၈၃ ဋေ
၆၁၈.၀၁ ဋေ
၆၈၄.၅၄ ဋေ
၆၅၂.၆၂ ဋေ
Operating income
၁၁၇.၅၈ ဋေ
၁၃၆.၄၂ ဋေ
၁၇၁.၅၈ ဋေ
၁၈၈.၁၇ ဋေ
Other non operating income
၂၁.၅၇ ကုဋေ
၂၀.၁၄ ကုဋေ
-၄၄.၁၉ ကုဋေ
၆.၄၀ ကုဋေ
EBT including unusual items
၁၃၃.၃၃ ဋေ
၁၅၀.၆၂ ဋေ
၂၀၀.၀၀ ဋေ
၂၀၆.၅၇ ဋေ
EBT excluding unusual items
၁၃၃.၃၃ ဋေ
၁၅၀.၆၂ ဋေ
၁၉၈.၈၅ ဋေ
၂၀၆.၅၇ ဋေ
Income tax expense
၃၄.၂၀ ကုဋေ
၃၆.၉၃ ကုဋေ
၅၀.၉၇ ကုဋေ
၄၇.၁၆ ကုဋေ
Effective tax rate
၂၅.၆၅%
၂၄.၅၂%
၂၅.၄၈%
၂၂.၈၃%
Other operating expenses
၁၆၃.၅၂ ဋေ
၁၆၅.၄၇ ဋေ
၈၈.၁၉ ကုဋေ
၁၇၀.၀၀ ဋေ
Net income
၉၈.၂၅ ကုဋေ
၁၁၃.၂၀ ဋေ
၁၄၈.၁၃ ဋေ
၁၅၇.၁၇ ဋေ
Net profit margin
၁၃.၆၄%
၁၅.၀၁%
၁၇.၃၀%
၁၈.၆၉%
Earnings per share
-
၂.၅၀
၃.၂၇
၃.၄၇
Interest and investment income
-
-
၂၇.၆၈ ကုဋေ
-
Interest expense
-၅.၈၂ ကုဋေ
-၅.၉၄ ကုဋေ
-၆.၃၁ ကုဋေ
-
Net interest expenses
-၅.၈၂ ကုဋေ
-၅.၉၄ ကုဋေ
၂၁.၃၇ ကုဋေ
-
Depreciation and amortization charges
၂၆.၉၂ ကုဋေ
၂၄.၃၃ ကုဋေ
၂၄.၂၉ ကုဋေ
၂၄.၈၆ ကုဋေ
EBITDA
၁၄၂.၅၉ ဋေ
၁၅၀.၄၃ ဋေ
၁၈၇.၀၇ ဋေ
၂၀၃.၆၇ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ